AN2 Therapeutics, Inc. (ANTX) Financials

ANTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 153.8 million 14.8 million
2023-06-30 98.9 million 11.2 million
2023-03-31 91.1 million 8.6 million
2022-12-31 102.6 million 7.2 million

ANTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -11.8 million 2.2 million
2023-06-30 -12.8 million 1.9 million
2023-03-31 -11.6 million 2.1 million
2022-12-31 -7.6 million 1.5 million

ANTX Net Income

No data available :(

ANTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 123.8 million - -
2023-06-30 95.3 million - 13000
2023-03-31 88.5 million - 34000
2022-12-31 96.1 million - 53000

ANTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 25.6 million
2023-06-30 19.5 million
2023-03-31 19.4 million
2022-12-31 19.4 million

ANTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 14.4 million 3.8 million -
2023-06-30 - 13.5 million 3.1 million -
2023-03-31 - 12.0 million 4.1 million -
2022-12-31 - 8.8 million 3.7 million -

ANTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - 21000
2023-03-31 - 19000
2022-12-31 - 20000

ANTX

Price: $2.56

52 week price:
2.28
22.22

Earnings Per Share: -2.80 USD

P/E Ratio: -7.50

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 47599

Market Capitalization: 90.7 million

Average Dividend Frequency: 3

Links: